Cleveland Biolabs Inc (NASDAQ:CBLI)

1.93
Delayed Data
As of May 22
 -0.16 / -7.66%
Today’s Change
1.84
Today|||52-Week Range
13.80
-66.14%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 2
2014
Quarter 3
2014
Quarter 4
2014
Quarter 1
2015
Revenue and IncomeNet Revenues562.1K415.1K1.4M607.3K
 
 
 
 
 
Depreciation And Amortization536.7K78.0K76.6K38.6K
 
 
 
 
 
 
Operating ExpensesGross Income----------
General Expenses4.0M3.8M4.8M3.9M
 
 
 
 
 
Research And Development2.3M2.1M2.8M1.6M
 
 
 
 
 
Total Operating Expenses4.6M3.9M4.8M3.9M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-4.0M-3.4M-3.5M-3.3M
 
 
 
 
 
Extraordinary Credit412.1K--998.9K0.00
 
 
 
Extraordinary Charge0.00-836.3K0.00-49.4K
 
 
 
Pre-Tax Equity Earnings-----285.5K-247.6K
 
 
 
Interest Expense On Debt623.8K--78.9K446.4K
 
 
 
 
Other Expenses92.6K-340.6K13.5M356.3K
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-4.1M-4.6M10.7M-3.7M
 
 
 
 
 
Minority Interest-170.4K-519.5K-588.0K-48.2K
 
 
 
 
 
Net Income-4.0M-4.1M11.3M-3.7M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS2.6M2.9M2.9M3.2M
 
 
 
 
 
Shares To Calculate EPS Diluted2.6M2.9M2.9M3.2M
 
 
 
 
 
 
Earnings Per ShareEPS-$1.60-$1.40$79.00-$1.14
 
 
 
 
 
EPS Diluted-$1.60-$1.40$3.95-$1.14
 
 
 
 
 
 

To view my watchlist

Not a member yet?

Sign up now for a free account